Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

B-OM's result is better with stricter criteria IMO.

In addition they reported "in the overall incidence of SOM through 60 Gy of radiation" We reported "cumulative radiation dose criteria of at least 55 Gy—the minimum treatment threshold for inclusion in the efficacy population." So we made it more challenging for ourselves by using the lower number of 55GY.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=137691726

Then there's oral rinse vs. IV. Good luck trying to get insurance to reimburse IV treatments for seven weeks when the alternative is an oral rinse.

BTW, what BP has partnered with Galera? I couldn't check because their website was down.